Skip to content
Research/Regenerative Aesthetics/Extracorporeal Shockwave Therapy

Extracorporeal Shockwave Therapy

Extracorporeal shockwave therapy (ESWT) is a non-invasive treatment that uses acoustic waves to promote healing and regeneration in tissues. It is primarily used for musculoskeletal conditions, enhancing blood flow and stimulating cellular repair processes. This therapy is gaining attention for its potential in improving recovery and function, which is relevant for longevity and health optimization.

Intelligence Profile

Clinical Applications

Extracorporeal Shockwave Therapy (ESWT) is a versatile treatment modality with various clinical applications, primarily focusing on pain reduction, tissue repair, and regeneration. Here's an overview of its uses based on recent studies:

  1. Endometriosis: Recent research demonstrates that low-energy ESWT can reduce inflammation and fibrosis in an estrogen-induced rat model of endometriosis. It remains effective even under conditions simulating menopause, suggesting potential benefits for managing endometriosis-related symptoms (PMID: 42546843).

  2. Tendon Injuries: ESWT has been successfully applied as an effective non-invasive treatment for tendon injuries. For instance, a case report showed excellent outcomes for a professional football player with an isolated peroneus longus tendon tear treated conservatively with focused ESWT (PMID: 42514199).

  3. Erectile Dysfunction: Low-intensity ESWT is being explored as a treatment for erectile dysfunction, particularly after radical prostatectomy. A systematic review and meta-analysis indicated promising results, and ongoing clinical trials are exploring its preventive and restorative potential in men's health (PMIDs: 42507290, 42489224; NCT06433596).

  4. Calcific Tendinitis: A randomized controlled trial assesses the efficacy of high-energy ESWT for treating rotator cuff calcific tendinitis, revealing comparable outcomes to ultrasound-guided needling treatments (PMID: 42496014).

  5. Temporomandibular Disorders (TMDs): Meta-analyses of randomized controlled trials have shown that ESWT effectively reduces pain and dysfunction in patients with TMDs, improving maximal mouth opening and overall function (PMID: 42494855).

  6. Lateral Epicondylitis: Ongoing trials are comparing ESWT to other treatments like corticosteroid injections and mesotherapy in patients with lateral epicondylitis, underlining its potential as a viable and non-invasive treatment option (NCT07043335, NCT02613455).

  7. Post-Stroke Spasticity: ESWT is also being explored in treating post-stroke ankle plantar flexor spasticity, particularly in patients who have received botulinum toxin treatment, although this trial has not yet started recruiting (NCT07695038).

  8. Postpartum Sacroiliac Pain: An unknown phase trial is evaluating the combination of shock wave therapy and core exercises for postpartum sacroiliac pain, highlighting a potential area of benefit (NCT06124365).

ESWT shows a promising and expanding role across various conditions, particularly in pain management and enhancing tissue healing. However, more studies and trials are needed to further establish effective protocols and long-term outcomes.

Disclaimer: This information is for educational purposes only and is not intended as medical advice. Please consult with a healthcare professional for specific medical advice.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.